RG 7986Alternative Names: RG7986
Latest Information Update: 02 Mar 2016
At a glance
- Originator Genentech
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Non-Hodgkin's lymphoma
Most Recent Events
- 29 Feb 2016 Phase-I clinical trials in Non-Hodgkin's lymphoma (Second-line therapy or greater) in USA (unspecified route)